Gov. Tony Evers
Press Release

Gov. Evers Signs Executive Order #39 Relating to Creating a Task Force on Reducing Prescription Drug Prices

"Picking up a medication shouldn’t break the bank, but it often does for our families and our seniors with the rising costs of healthcare and prescription drugs."

By - Aug 21st, 2019 02:31 pm

MADISON – Gov. Tony Evers yesterday signed Executive Order #39 creating a task force on reducing prescription drug prices in Wisconsin.

“Picking up a medication shouldn’t break the bank, but it often does for our families and our seniors with the rising costs of healthcare and prescription drugs,” said Gov. Evers. “We have to do more to make sure that healthcare is affordable and accessible, and I’m looking forward to our Task Force on Reducing Prescription Drug Prices helping us get to work on reducing costs for prescription drugs in Wisconsin.”

The Governor’s Task Force on Reducing Prescription Drug Prices is charged with gathering and analyzing data on development, pricing, distribution, and purchasing of prescription drugs, analyzing other states’ strategies in reducing prescription drug prices and identifying opportunities to work with other states and the federal government, and making recommendations for reducing prescription drug prices in Wisconsin.

The governor’s executive order can be found here.

Office of the Governor

NOTE: This press release was submitted to Urban Milwaukee and was not written by an Urban Milwaukee writer. While it is believed to be reliable, Urban Milwaukee does not guarantee its accuracy or completeness.

Mentioned in This Press Release

People:

Leave a Reply

You must be an Urban Milwaukee member to leave a comment. Membership, which includes a host of perks, including an ad-free website, tickets to marquee events like Summerfest, the Wisconsin State Fair and the Florentine Opera, a better photo browser and access to members-only, behind-the-scenes tours, starts at $9/month. Learn more.

Join now and cancel anytime.

If you are an existing member, sign-in to leave a comment.

Have questions? Need to report an error? Contact Us